CL2012000885A1 - Compuestos derivados de feniloxadiazol, inhibidores de las prostaglandinas sintasa (pgds); procedimiento de preparacion de dichos compuestos; compuestos intermediarios; composicion farmaceutica que comprende dichos compuestos, util para tratar un trastorno inflamatorio o alergico. - Google Patents
Compuestos derivados de feniloxadiazol, inhibidores de las prostaglandinas sintasa (pgds); procedimiento de preparacion de dichos compuestos; compuestos intermediarios; composicion farmaceutica que comprende dichos compuestos, util para tratar un trastorno inflamatorio o alergico.Info
- Publication number
- CL2012000885A1 CL2012000885A1 CL2012000885A CL2012000885A CL2012000885A1 CL 2012000885 A1 CL2012000885 A1 CL 2012000885A1 CL 2012000885 A CL2012000885 A CL 2012000885A CL 2012000885 A CL2012000885 A CL 2012000885A CL 2012000885 A1 CL2012000885 A1 CL 2012000885A1
- Authority
- CL
- Chile
- Prior art keywords
- compounds
- pharmaceutical composition
- inflammatory
- phenyloxadiazole
- pgds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
ESTA INVENCIÓN SE REFIERE A UN COMPUESTO DE FÓRMULA (1): EN LA QUE RL, R2 Y R3 SON COMO SE DEFINEN EN LA PRESENTE MEMORIA, A UNA COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE EL COMPUESTO, COMPUESTOS INTERMEDIARIOS Y A UN PROCEDIMIENTO PARA FABRICAR DICHOS COMPUESTOS, Y AL USO DEL COMPUESTO PARA TRATAR TRASTORNOS INFLAMATORIOS Y/O ALÉRGICOS, PARTICULARMENTE TRASTORNOS TALES COMO RINITIS ALÉRGICA, ASMA, ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA (COPD) Y DEGENERACIÓN MACULAR RELACIONADA CON LA EDAD (AMD).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24969309P | 2009-10-08 | 2009-10-08 | |
| FR1056094 | 2010-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2012000885A1 true CL2012000885A1 (es) | 2012-08-31 |
Family
ID=69650455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2012000885A CL2012000885A1 (es) | 2009-10-08 | 2012-04-05 | Compuestos derivados de feniloxadiazol, inhibidores de las prostaglandinas sintasa (pgds); procedimiento de preparacion de dichos compuestos; compuestos intermediarios; composicion farmaceutica que comprende dichos compuestos, util para tratar un trastorno inflamatorio o alergico. |
Country Status (2)
| Country | Link |
|---|---|
| US (2) | US20200383982A1 (es) |
| CL (1) | CL2012000885A1 (es) |
-
2012
- 2012-04-05 CL CL2012000885A patent/CL2012000885A1/es unknown
-
2019
- 2019-12-23 US US16/724,827 patent/US20200383982A1/en not_active Abandoned
-
2021
- 2021-04-09 US US17/226,882 patent/US20210330671A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20200383982A1 (en) | 2020-12-10 |
| US20210330671A1 (en) | 2021-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY29840A1 (es) | Compuestos de pirimidina amida como inhibidores de pgds | |
| UY32938A (es) | Derivados de feniloxadiazol como agentes inhibidores de las pgds | |
| ECSP088741A (es) | Derivados de benzotriazol como agonistas del adrenoreceptor beta2 | |
| MX353461B (es) | PROCESOS PARA PREPARAR COMPUESTOS ÚTILES COMO INHIBIDORES DE CINASA ATAXIA TELANGIECTASIA MUTADA Y Rad3 RELACIONADOS (ATR). | |
| ECSP14013173A (es) | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil) carbamimidoil)pirazina-2-carboxamida | |
| SV2009002861A (es) | Compuestos de pirimidina amida como inhibidores de pgds | |
| BR112013023517A2 (pt) | "inibidores de produção de leucotrieno, seus usos, e composição farmacêutica" | |
| BR112013025387A2 (pt) | análogos substituídos da n-fenilpirimidin-2-amina como inibidores da quinase axl | |
| GT200900289A (es) | Compuestos organicos.- | |
| BR112014002202A2 (pt) | macrociclos como inibidores de fator xia | |
| NI200700296A (es) | Imidazoquinolinas como inhibidores de cinasa de lipido | |
| BR112015020350A2 (pt) | derivados de 6-(5-hidroxi-1h-pirazol-1-il)nicotinamida e seu uso como inibidores de phd | |
| CU24187B1 (es) | Derivados sustituidos de imidazopiridazinas útiles para el tratamiento o profilaxis de trastornos hiperproliferativos y la angiogénesis | |
| TN2014000254A1 (en) | Substituted triazolopyridines and their use as ttk inhibitors | |
| UY34959A (es) | Dihidropiridona p1 como inhibidores del factor xia | |
| ECSP13012494A (es) | Inhibidores de oxadiazol de la producción de leucotrieno. | |
| CY1122500T1 (el) | Φαρμακευτικη συνθεση που περιεχει παραγωγα γλουταριμιδιου, και εφαρμογη αυτης για την αγωγη ηωσινοφιλικων νοσων | |
| CR20130693A (es) | Composición farmacéutica ortalmológica tópica que contiene regorafenib | |
| AR080527A1 (es) | Una pirimidina sustituida como un antagonista del receptor de la postaglandina d2 | |
| CL2012000885A1 (es) | Compuestos derivados de feniloxadiazol, inhibidores de las prostaglandinas sintasa (pgds); procedimiento de preparacion de dichos compuestos; compuestos intermediarios; composicion farmaceutica que comprende dichos compuestos, util para tratar un trastorno inflamatorio o alergico. | |
| MX2010008685A (es) | Farmacoforos duales-antagonistas muscarinicos de pde4. | |
| AU2012312301A8 (en) | Compounds useful as inhibitors of choline kinase | |
| WO2013040412A3 (en) | Methods for inhibiting bacteria growth | |
| UY30988A1 (es) | Compuestos de pirimidina hidrazida como inhibidores de pgds | |
| CU20100214A7 (es) | Imidazoquinolinas como inhibidores de cinasa de lípido |